Effect of perceived and objectively-assessed frailty on outcomes in edoxaban-treated patients with atrial fibrillation: data from the ETNA-AF-Europe 4-year follow-up

Back

ESC Professional Premium Access

Effect of perceived and objectively-assessed frailty on outcomes in edoxaban-treated patients with atrial fibrillation: data from the ETNA-AF-Europe 4-year follow-up

Session: Atrial fibrillation stroke prevention with oral anticoagulants

Topic: Oral Anticoagulation

Speaker: Associate Professor S. Fumagalli (Florence, IT)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Associate Professor Stefano Fumagalli

Geriatric Intensive Care Unit, Florence (Italy)

3 presentations

1 follower

6 more presentations in this session

Impact of proton pump inhibitor on quality of anticoagulant control and outcomes in atrial fibrillation patients treated with an oral anticoagulant in the COOL-AF registry.

Speaker: Doctor P. Chichareon (Hat Yai, TH)

Comparative analysis of oral anticoagulation therapy in Asian patients with atrial fibrillation and end-stage renal disease: a nationwide population-based cohort study

Speaker: Doctor S. Lee (Seoul, KR)

Factors associated with delayed treatment initiation of oral anticoagulants among Medicare patients with atrial fibrillation

Speaker: Doctor X. Luo (Groton, US)

Oral anticoagulation among frail patients with atrial fibrillation: assessment of net clinical benefit in a nationwide cohort

Speaker: Ms M. Soegaard (Aalborg, DK)

Relationship between care speciality and atrial fibrillation outcomes in the GARFIELD-AF registry

Speaker: Doctor C. Camm (Oxford, GB)

Access the full session

Atrial fibrillation stroke prevention with oral anticoagulants

Speakers: Associate Professor S. Fumagalli, Doctor P. Chichareon, Doctor S. Lee, Doctor X. Luo, Ms M. Soegaard...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources